Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Quantitative analysis of Helicobacter pylori infection in a mouse model.

Smythies LE, Chen JA, Lindsey JR, Ghiara P, Smith PD, Waites KB.

J Immunol Methods. 2000 Aug 28;242(1-2):67-78.

PMID:
10986390
2.

Immunohistochemical study of lymphocyte populations infiltrating the gastric mucosa of beagle dogs experimentally infected with Helicobacter pylori.

Rossi G, Fortuna D, Pancotto L, Renzoni G, Taccini E, Ghiara P, Rappuoli R, Del Giudice G.

Infect Immun. 2000 Aug;68(8):4769-72.

3.

Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants.

Kamradt AE, Greiner M, Ghiara P, Kaufmann SH.

Microbes Infect. 2000 May;2(6):593-7.

PMID:
10884609
4.

Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.

Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD.

J Immunol. 2000 Jul 15;165(2):1022-9.

5.

A conventional beagle dog model for acute and chronic infection with Helicobacter pylori.

Rossi G, Rossi M, Vitali CG, Fortuna D, Burroni D, Pancotto L, Capecchi S, Sozzi S, Renzoni G, Braca G, Del Giudice G, Rappuoli R, Ghiara P, Taccini E.

Infect Immun. 1999 Jun;67(6):3112-20.

6.

The inflammatory response in CD1 mice shortly after infection with a CagA+/VacA+ Helicobacter pylori strain.

van Doorn NE, van Rees EP, Namavar F, Ghiara P, Vandenbroucke-Grauls CM, de Graaff J.

Clin Exp Immunol. 1999 Mar;115(3):421-7.

7.

Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing.

Konturek PC, Brzozowski T, Konturek SJ, Stachura J, Karczewska E, Pajdo R, Ghiara P, Hahn EG.

Aliment Pharmacol Ther. 1999 Mar;13(3):333-46.

8.

Experimental model of Helicobacter pylori infection.

Del Giudice G, Ghiara P, Rappuoli R.

Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S261-3. Review.

PMID:
10077750
9.

Mouse model of gastric infection with cytotoxin-expressing strain of Helicobacter pylori in studying of pathogenesis of chronic gastric ulcer.

Konturek PC, Brzozowski T, Konturek SJ, Karczewska E, Pajdo R, Ghiara P, Hahn EG.

J Gastroenterol Hepatol. 1998 Nov;13(S3):S178-S184. doi: 10.1111/j.1440-1746.1998.tb01873.x.

PMID:
28976668
10.

Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori.

Brzozowski T, Konturek PC, Konturek SJ, Karczewska E, Pajdo R, Stachura J, Ghiara P, Hahn EG.

J Physiol Pharmacol. 1998 Sep;49(3):387-403.

PMID:
9789792
11.
12.

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

Marchetti M, Rossi M, Giannelli V, Giuliani MM, Pizza M, Censini S, Covacci A, Massari P, Pagliaccia C, Manetti R, Telford JL, Douce G, Dougan G, Rappuoli R, Ghiara P.

Vaccine. 1998 Jan;16(1):33-7.

PMID:
9607006
13.

Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization.

De Magistris MT, Pizza M, Douce G, Ghiara P, Dougan G, Rappuoli R.

Dev Biol Stand. 1998;92:123-6.

PMID:
9554265
14.

Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.

Ghiara P, Rossi M, Marchetti M, Di Tommaso A, Vindigni C, Ciampolini F, Covacci A, Telford JL, De Magistris MT, Pizza M, Rappuoli R, Del Giudice G.

Infect Immun. 1997 Dec;65(12):4996-5002.

15.

Detoxification of the Helicobacter pylori cytotoxin.

Manetti R, Massari P, Marchetti M, Magagnoli C, Nuti S, Lupetti P, Ghiara P, Rappuoli R, Telford JL.

Infect Immun. 1997 Nov;65(11):4615-9.

16.

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53.

17.

Prospects for the development of a vaccine against Helicobacter pylori.

Telford JL, Ghiara P.

Drugs. 1996 Dec;52(6):799-804. Review.

PMID:
8957151
18.

Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.

Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, De Vries T, Quan H, Verboom T, Maaskant JJ, Ghiara P, Kuipers EJ, Bloemena E, Tadema TM, Townsend RR, Tyagarajan K, Crothers JM Jr, Monteiro MA, Savio A, De Graaff J.

Infect Immun. 1996 Jun;64(6):2031-40.

19.

Gastric antisecretory and anti-ulcer actions of IL-1 in rat involve different IL-1 receptor types.

Mugridge KG, Perretti M, Ghiara P, Galeotti CL, Melli M, Parente L.

Am J Physiol. 1995 Nov;269(5 Pt 1):G763-9.

PMID:
7491969
20.

Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Ghiara P, Marchetti M, Blaser MJ, Tummuru MK, Cover TL, Segal ED, Tompkins LS, Rappuoli R.

Infect Immun. 1995 Oct;63(10):4154-60.

21.

Evidence that the interleukin-1 beta-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors.

Mirtella A, Tringali G, Guerriero G, Ghiara P, Parente L, Preziosi P, Navarra P.

J Neuroimmunol. 1995 Sep;61(2):171-7.

PMID:
7593552
22.

Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells.

Fratelli M, Gagliardini V, Galli G, Gnocchi P, Ghiara P, Ghezzi P.

Blood. 1995 Jun 15;85(12):3532-7.

23.

Development of a mouse model of Helicobacter pylori infection that mimics human disease.

Marchetti M, Aricò B, Burroni D, Figura N, Rappuoli R, Ghiara P.

Science. 1995 Mar 17;267(5204):1655-8.

PMID:
7886456
24.

Cytokines in the viviparous reproduction of squamate reptiles: interleukin-1 alpha (IL-1 alpha) and IL-1 beta in placental structures of a skink.

Paulesu L, Romagnoli R, Marchetti M, Cintorino M, Ghiara P, Guarino FM, Ghiara G.

Placenta. 1995 Mar;16(2):193-205.

PMID:
7792282
25.

Pathogenesis of Helicobacter pylori and perspectives of vaccine development against an emerging pathogen.

Rappuoli R, Covacci A, Ghiara P, Telford J.

Behring Inst Mitt. 1994 Dec;(95):42-8. Review.

PMID:
7755508
26.

Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines.

Telford JL, Covacci A, Ghiara P, Montecucco C, Rappuoli R.

Trends Biotechnol. 1994 Oct;12(10):420-6. Review.

PMID:
7765388
27.

Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, et al.

J Exp Med. 1994 May 1;179(5):1653-58.

28.

Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: role of Bordetella pertussis cells in toxicity.

Fantuzzi G, Sironi M, Delgado R, Cantoni L, Rizzardini M, Carelli M, Marsili I, Ghiara P, Ghezzi P.

Infect Immun. 1994 Jan;62(1):29-32.

29.

Importance of brain IL-1 type II receptors in fever and thermogenesis in the rat.

Luheshi G, Hopkins SJ, Lefeuvre RA, Dascombe MJ, Ghiara P, Rothwell NJ.

Am J Physiol. 1993 Oct;265(4 Pt 1):E585-91.

PMID:
8238334
30.

Increasing the immunogenicity of protein antigens through the genetic insertion of VQGEESNDK sequence of human IL-1 beta into their sequence.

Beckers W, Villa L, Gonfloni S, Castagnoli L, Newton SM, Cesareni G, Ghiara P.

J Immunol. 1993 Aug 15;151(4):1757-64.

PMID:
8345181
31.

A chimeric type II/type I interleukin-1 receptor can mediate interleukin-1 induction of gene expression in T cells.

Heguy A, Baldari CT, Censini S, Ghiara P, Telford JL.

J Biol Chem. 1993 May 15;268(14):10490-4.

32.

[Interleukin-1 beta in the gingival tissues of patients with periodontitis: immunohistochemical data].

Lo Storto S, Ghiara P, Di Murro C, Floridi G, Bonucci E.

Minerva Stomatol. 1993 Jan-Feb;42(1-2):19-27. Italian.

PMID:
8510615
34.

Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvants.

Tagliabue A, Ghiara P, Boraschi D.

Res Immunol. 1992 Jun;143(5):563-8; discussion 581-2. Review. No abstract available.

PMID:
1439139
35.

Binding and internalization of the 163-171 fragment of human IL-1 beta.

Boraschi D, Ghiara P, Scapigliati G, Villa L, Sette A, Tagliabue A.

Cytokine. 1992 May;4(3):201-4.

PMID:
1386756
36.

Differential inhibition of IL-1 beta activities and receptor binding by monoclonal antibodies mapping within a discrete region of the protein.

Boraschi D, Villa L, Ghiara P, Presentini R, Bossù P, Censini S, Nucci D, Massone A, Rossi R, Flad HD, et al.

Lymphokine Cytokine Res. 1991 Oct;10(5):377-84.

PMID:
1722713
37.

Binding of IL-1 beta to IL-1R type II at single cell level.

Stoppacciaro A, Bossu P, Ghiara P, Ruco LP, Censini S, Scapigliati G, Nuti S, Tagliabue A, Baroni CD, Boraschi D.

J Immunol. 1991 Sep 1;147(5):1561-6.

PMID:
1831828
38.

Endothelial cells express the interleukin-1 receptor type I.

Boraschi D, Rambaldi A, Sica A, Ghiara P, Colotta F, Wang JM, de Rossi M, Zoia C, Remuzzi G, Bussolino F, et al.

Blood. 1991 Sep 1;78(5):1262-7.

39.
40.

Quantitation of biologically active IL-1 by a sensitive assay based on immobilized human IL-1 receptor type II (IL-1RII).

Scapigliati G, Bossu P, Censini S, Tagliabue A, Boraschi D, Ghiara P.

J Immunol Methods. 1991 Apr 8;138(1):31-8.

PMID:
1826916
41.

Mechanism of acute toxicity of IL-1 beta in mice.

Boraschi D, Villa L, Ghiara P, Tagliabue A, Mengozzi M, Solito E, Parente L, Silvestri S, Van Damme J, Ghezzi P.

Eur Cytokine Netw. 1991 Jan-Feb;2(1):61-7.

PMID:
1873493
42.

Defining the structural requirements of a biologically active domain of human IL-1 beta.

Boraschi D, Antoni G, Perin F, Villa L, Nencioni L, Ghiara P, Presentini R, Tagliabue A.

Eur Cytokine Netw. 1990 Mar-Apr;1(1):21-6.

PMID:
2102359
43.

Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo.

Boraschi D, Villa L, Volpini G, Bossù P, Censini S, Ghiara P, Scapigliat G, Nencioni L, Bartalini M, Matteucci G, et al.

Eur J Immunol. 1990 Feb;20(2):317-21.

PMID:
2311646
44.

The 163-171 peptide of human IL-1 beta.

Boraschi D, Ghiara P, Villa L, Antoni G, Tagliabue A.

Prog Clin Biol Res. 1990;349:365-74. No abstract available.

PMID:
2144645
45.

IL-1 receptor subtypes possess distinct binding properties for IL-1 alpha and IL-1 beta.

Ghiara P, Scapigliati G, Censini S, Bartalini M, Bossù P, Armellini D, Nuti S, Volpini G, Dallai R, Boraschi D, et al.

Prog Clin Biol Res. 1990;349:271-84. No abstract available.

PMID:
2144641
46.

Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells.

Scapigliati G, Ghiara P, Bartalini M, Tagliabue A, Boraschi D.

FEBS Lett. 1989 Jan 30;243(2):394-8.

47.

Interleukin 1 and its synthetic peptides as adjuvants for poorly immunogenic vaccines.

Antoni G, Presentini R, Perin F, Nencioni L, Villa L, Censini S, Ghiara P, Volpini G, Bossu' P, Tagliabue A, et al.

Adv Exp Med Biol. 1989;251:153-60. Review.

PMID:
2692425
48.

Use of ZetaPrep cartridge for the purification of human recombinant interleukin 1 beta.

Casagli MC, Borri MG, D'Ettorre C, Galeotti CL, Di Liegro C, Ghiara P, Antoni G.

Prep Biochem. 1989;19(1):23-35.

PMID:
2662172
49.

In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta.

Boraschi D, Nencioni L, Villa L, Censini S, Bossù P, Ghiara P, Presentini R, Perin F, Frasca D, Doria G, et al.

J Exp Med. 1988 Aug 1;168(2):675-86.

50.

Enhancement of in vivo immune response by tumor necrosis factor.

Ghiara P, Boraschi D, Nencioni L, Ghezzi P, Tagliabue A.

J Immunol. 1987 Dec 1;139(11):3676-9.

PMID:
3500228

Supplemental Content

Loading ...
Support Center